Craneware drops as HRSA pilot programme halt impacts revenue

Craneware

20/01/2026 09:24

**  Shares of software licensing firm Craneware CRW.L down 5.5% at 1772p

** Halt in co's HRSA pilot, a reimbursement programme, reduced half-yearly ARR and revenue, with impacted contracts no longer contributing as expected during period

** However, co says it delivered 6% YoY revenue growth to about $106 mln in H1, while ARR grew ~4% to $184.3 mln

** In 2025, stock fell 8%

 (Reporting by Tuhina in Bengaluru)

 ((Tuhina@thomsonreuters.com))